Spectral Analysis of Breast Cancer on Tissue Microarrays: Seeing Beyond Morphology
Annual rept. 15 Apr 2003-14 Apr 2004
YALE UNIV NEW HAVEN CT SCHOOL OF MEDICINE
Pagination or Media Count:
Spectral imaging is a mechanism of tissue examination that combines spectral color with spatial information. The Varispectm device fractionates the light into 10 nm bands and then collects images containing a full spectral profile for each pixel. The resulting spectral profile is then analyzed using a genetic algorithm based software package called GENIE. GENIE allows combination of spectral and spatial information for binary inclusion into user defined classes. This IDEA grant proposed examination of the spectral signatures of breast cancer to distinguish benign cells from malignant cells allowing diagnosis, classification, and possibly prediction of outcomes in breast cancer. The first stages of the grant analyzed tissue microarray spots, to assess our ability to distinguish benign from malignant tissue using very easy cases. This has been completed with good sensitivity and specificity and more challenging specimens are now being assessed. The second part of the proposal focused on application of this technology to cytology specimens. Due to some difficulties in obtaining optimal material for breast cytology, urine cytology specimens have been used as a model system Using this model, we have been able to distinguish benign from malignant cells with high accuracy and even shown good accuracy in adjudication of atypical specimens.
- Anatomy and Physiology
- Medicine and Medical Research